These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 289863)

  • 21. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
    Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The saralasin test in the diagnosis of hypertension (author's transl)].
    Bönner G; Helber A; Meurer KA; Hummerich W; Wambach G; Kaufmann W
    Dtsch Med Wochenschr; 1979 Mar; 104(12):432-7. PubMed ID: 436589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [What role does the renin-angiotensin system have in the pathogenesis of hypertension?].
    Gross F; Dietz R; Lüth JB; Mann JF
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():177-87. PubMed ID: 613563
    [No Abstract]   [Full Text] [Related]  

  • 25. [Significance of renin-angiotensin system inhibitors in the diagnosis of hypertension].
    Stumpe KO; Kolloch RE; Overlack A
    Med Welt; 1977 Oct; 28(41):1645-9. PubMed ID: 927124
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
    Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
    Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of saralasin in hypertensive uremic patients under periodic hemodialysis treatment].
    Cappelli G; Vagge R; Lamperi S
    Minerva Nefrol; 1979; 26(1):5-8. PubMed ID: 471322
    [No Abstract]   [Full Text] [Related]  

  • 28. Saralasin test as a diagnostic and prognostic aid in renovascular hypertensive patients subjected to renal operation.
    Poutasse EF; Gonzalez-Serva L; Wendelken JR; Franz JP
    Trans Am Assoc Genitourin Surg; 1979; 71():96-100. PubMed ID: 545821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [SAR1, ALA8]-Angiotensin II (saralasin): a symposium. Introduction.
    Vaughan ED; Peach MJ
    Kidney Int Suppl; 1979 Mar; (9):S1-2. PubMed ID: 289858
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of saralasin in the recognition of angiotensinogenic hypertension.
    Streeten DH; Dalakos TG; Anderson GH
    Prog Biochem Pharmacol; 1976; 12():214-26. PubMed ID: 1019165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of a competitive antagonist of angiotensin II (saralasin) in the diagnosis and therapy of arterial hypertension].
    Mazza F; Messore T; Catzola A; Corvino A; Genovese A; Catalano M; Mercone G
    Recenti Prog Med; 1983 Apr; 74(4):415-29. PubMed ID: 6348901
    [No Abstract]   [Full Text] [Related]  

  • 33. Saralasin acetate test in renal transplant hypertension. Report of 17 cases and a review of the literature.
    Zawada ET; Green SJ; Johnson MD; Reinitz ER; Mauakkassa W; Sica D; Goldman M
    Arch Intern Med; 1984 Jan; 144(1):65-8. PubMed ID: 6362596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of saralasin on 20 hypertensive patients (author's transl)].
    Plaza de los Reyes M; Passalacqua W; Plaza de los Reyes X; Pla C; Campino C
    Rev Med Chil; 1980 Feb; 108(2):115-20. PubMed ID: 7017869
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiotensin II blockade by saralasin in the evaluation of hypertension in children.
    Favre L; Boerth RC; Braren V; Dean RH; Hollifield JW
    Kidney Int Suppl; 1979 Mar; (9):S75-82. PubMed ID: 289867
    [No Abstract]   [Full Text] [Related]  

  • 36. Saralasin test as a diagnostic and prognostic aid in renovascular hypertensive patients subjected to renal operation.
    Poutasse EF; Gonzalez-Serva L; Wendelken JR; Franz JP
    J Urol; 1980 Mar; 123(3):306-10. PubMed ID: 6987415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of renovascular hypertension: saralasin test versus renin determinations.
    Marks LS; Maxwell MH; Smith RB; Cahill PJ; Kaufman JJ
    J Urol; 1976 Oct; 116(4):406-9. PubMed ID: 1053323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
    Fagard R; Amery A; Ljnen P; Reybrouck T; Billiet L
    Prog Biochem Pharmacol; 1976; 12():242-9. PubMed ID: 1019167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differential diagnosis of hypertension using the angiotensin II antagonist saralasin].
    Knauf H; Burmeister P; Büttner C; Hoppe-Seyler G; Schollmeyer P
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():214-5. PubMed ID: 613578
    [No Abstract]   [Full Text] [Related]  

  • 40. Angiotensin antagonists as diagnostic and pharmacologic tools.
    Pettinger WA; Mitchell HC
    Prog Biochem Pharmacol; 1976; 12():203-13. PubMed ID: 798203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.